ALGS Conference

Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Published September 02, 2025 at 08:05 PM

(NASDAQ:ALGS) SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that members of management will present at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025.